Emily N Larsen1,2,3, Gillian Ray-Barruel3,4,5, Mari Takashima1,3,4, Nicole Marsh1,2,3,4, Christopher R Friese6, Vineet Chopra7, Evan Alexandrou3,8,9, Claire M Rickard1,2,3,4,5. 1. School of Nursing and Midwifery, Griffith University, Brisbane, QLD, Australia. 2. Nursing and Midwifery Research Centre, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. 3. Alliance for Vascular Access Teaching and Research, Griffith University, Brisbane, QLD, Australia. 4. School of Nursing, Midwifery and Social Work, The University of Queensland, Brisbane, QLD, Australia. 5. Herston Infectious Diseases Institute, Metro North Health, Brisbane, QLD, Australia. 6. School of Nursing and Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA. 7. Department of Medicine, University of Colorado, Denver, Colorado 80204, USA. 8. School of Nursing and Midwifery, Western Sydney University, Sydney, NSW, Australia. 9. Liverpool Hospital, Sydney, NSW, Australia.
Abstract
Aim: To determine peripheral intravenous catheter (PIVC) characteristics, complications and risk factors among patients in cancer units. Methods: A secondary analysis of a global, cross-sectional study (127 hospitals in 24 countries). Participants (≥18 years) admitted to cancer units were assessed once for PIVC characteristics and the presence of complications. Variables included patient demographics, device characteristics, treatment details, and device and/or site complications. PIVC characteristics were presented using qualitative descriptors; mixed-effects logistic regression models determined risk factors for PIVC complications. Results: In total, 1,807 participants (1,812 PIVCs) were included; 12% (n=215) of PIVCs presented with complications. Risk factors included: insertion by doctors; insertion in ED and ambulance/other locations; poor PIVC dressing integrity; dwell time ≥49 hours; and administration of colloids/blood products and antiemetics. Conclusions: At least one in ten PIVCs in cancer units present with complications; regular PIVC assessment and improved dressing integrity is likely to reduce risk and improve outcomes.
Aim: To determine peripheral intravenous catheter (PIVC) characteristics, complications and risk factors among patients in cancer units. Methods: A secondary analysis of a global, cross-sectional study (127 hospitals in 24 countries). Participants (≥18 years) admitted to cancer units were assessed once for PIVC characteristics and the presence of complications. Variables included patient demographics, device characteristics, treatment details, and device and/or site complications. PIVC characteristics were presented using qualitative descriptors; mixed-effects logistic regression models determined risk factors for PIVC complications. Results: In total, 1,807 participants (1,812 PIVCs) were included; 12% (n=215) of PIVCs presented with complications. Risk factors included: insertion by doctors; insertion in ED and ambulance/other locations; poor PIVC dressing integrity; dwell time ≥49 hours; and administration of colloids/blood products and antiemetics. Conclusions: At least one in ten PIVCs in cancer units present with complications; regular PIVC assessment and improved dressing integrity is likely to reduce risk and improve outcomes.
Authors: Evan Alexandrou; Gillian Ray-Barruel; Peter J Carr; Steven A Frost; Sheila Inwood; Niall Higgins; Frances Lin; Laura Alberto; Leonard Mermel; Claire M Rickard Journal: J Hosp Med Date: 2018-05-30 Impact factor: 2.960
Authors: E Meyer; J Beyersmann; H Bertz; S Wenzler-Röttele; R Babikir; M Schumacher; F D Daschner; H Rüden; M Dettenkofer Journal: Bone Marrow Transplant Date: 2007-02 Impact factor: 5.483
Authors: Vineet Chopra; Scott A Flanders; Sanjay Saint; Scott C Woller; Naomi P O'Grady; Nasia Safdar; Scott O Trerotola; Rajiv Saran; Nancy Moureau; Stephen Wiseman; Mauro Pittiruti; Elie A Akl; Agnes Y Lee; Anthony Courey; Lakshmi Swaminathan; Jack LeDonne; Carol Becker; Sarah L Krein; Steven J Bernstein Journal: Ann Intern Med Date: 2015-09-15 Impact factor: 25.391
Authors: I Raad; R Hachem; H Hanna; P Bahna; I Chatzinikolaou; X Fang; Y Jiang; R F Chemaly; K Rolston Journal: Eur J Clin Microbiol Infect Dis Date: 2007-08 Impact factor: 3.267